A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept

By Lynde Charles W.   Gupta Aditya K.   Guenther Lyn   Poulin Yves   Levesque Annie   Bissonnette Robert  

Journal of Dermatological Treatment, Vol. 23, Iss. 4, 2012-08 ,pp. : 261-267

Informa Healthcare

Access to resources Recommend Favorite

The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial)

By Strohal Robert  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 169-178

Informa Healthcare

Access to resources Recommend Favorite

Efficiency and Safety of Etanercept after Acute Hepatitis Induced by Infliximab for Psoriasis

By Kluger Nicolas   Girard Céline   Guillot Bernard   Bessis Didier  

Acta Dermato-Venereologica, Vol. 89, Iss. 3, 2009-05 ,pp. : 332-333

Medical Journals Limited

Access to resources Recommend Favorite

Improvement in Psoriasis Area and Severity Index Score Predicts Improvement in Skin Pain Over Time in Patients with Psoriasis

By Ljosaa Tone Marte   Stubhaug Audun   Mork Cato   Moum Torbjorn   Wahl Astrid K.  

Acta Dermato-Venereologica, Vol. 93, Iss. 3, 2013-03 ,pp. : 330-334

Medical Journals Limited

Access to resources Recommend Favorite

A retrospective analysis of combination methotrexate–cyclosporine therapy in moderate–severe psoriasis

By Mohanan Saritha   Ramassamy Sivaranjini   Chandrashekar Laxmisha   Thappa Devinder Mohan  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 50-53

Informa Healthcare

Access to resources Recommend Favorite